It has been reported that hepatocellular carcinoma cells can specifically recognize various ligands such as galactose, N-acetylgalactosamine, and glucose via the ASGPR expressed on their surfaces [235] Thus, ASGPR-mediated DDS have gained interest in the field of hepatocellular carcinoma treatment. This evidence concerns the gene ASGR1 and hepatocellular carcinoma.